BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 28507029)

  • 41. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.
    Harmala LA; Ingulli EG; Curtsinger JM; Lucido MM; Schmidt CS; Weigel BJ; Blazar BR; Mescher MF; Pennell CA
    J Immunol; 2002 Nov; 169(10):5622-9. PubMed ID: 12421941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inclusion of non-target antigen in vaccination favors generation of OVA specific CD4 memory T cells.
    MohanKrishnan A; Patel H; Bhurani V; Parmar R; Yadav N; Dave N; Rana S; Gupta S; Madariya J; Vyas P; Dalai SK
    Cell Immunol; 2019 Mar; 337():1-14. PubMed ID: 30773218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.
    Kutzler MA; Robinson TM; Chattergoon MA; Choo DK; Choo AY; Choe PY; Ramanathan MP; Parkinson R; Kudchodkar S; Tamura Y; Sidhu M; Roopchand V; Kim JJ; Pavlakis GN; Felber BK; Waldmann TA; Boyer JD; Weiner DB
    J Immunol; 2005 Jul; 175(1):112-23. PubMed ID: 15972637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
    Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
    Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells.
    Zhang XY; Liu XG; Wang W; Wang WC; Gao XM
    Immunology; 2003 Apr; 108(4):465-73. PubMed ID: 12667208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses.
    Bioley G; Lassus A; Bussat P; Terrettaz J; Tranquart F; Corthésy B
    Biomaterials; 2012 Sep; 33(25):5935-46. PubMed ID: 22652023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.
    Takeda K; Dow SW; Miyahara N; Kodama T; Koya T; Taube C; Joetham A; Park JW; Dakhama A; Kedl RM; Gelfand EW
    J Immunol; 2009 Jul; 183(1):181-90. PubMed ID: 19542429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH
    Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
    Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
    PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
    Colluru VT; McNeel DG
    Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvanting influenza hemagglutinin vaccine with a human pulmonary surfactant-mimicking synthetic compound SF-10 induces local and systemic cell-mediated immunity in mice.
    Kim H; Kimoto T; Sakai S; Takahashi E; Kido H
    PLoS One; 2018; 13(1):e0191133. PubMed ID: 29370185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
    Karan D; Krieg AM; Lubaroff DM
    Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcellular Localization of Antigen in Keratinocytes Dictates Delivery of CD4
    Bąbała N; Bovens A; de Vries E; Iglesias-Guimarais V; Ahrends T; Krummel MF; Borst J; Bins AD
    Cancer Immunol Res; 2018 Jul; 6(7):835-847. PubMed ID: 29764836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of antigen-specific CD4
    Weilhammer D; Dunkle AD; Blanchette CD; Fischer NO; Corzett M; Lehmann D; Boone T; Hoeprich P; Driks A; Rasley A
    Vaccine; 2017 Mar; 35(11):1475-1481. PubMed ID: 28214044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
    J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.